Liver transplant meeting 19th September 2017 Dr Tu Vinh Luong - PowerPoint PPT Presentation

Feb 03, 2023 •126 likes •377 views

Liver transplant meeting 19th September 2017 Dr Tu Vinh Luong Royal Free Hospital Royal Free Hospital - Case A Female 41 years Liver transplant in Feb 2017 for PBC. Stable at clinical follow-ups until July 2017 when a liver biopsy

Liver transplant meeting 19th September 2017 Dr Tu Vinh Luong Royal Free Hospital
Royal Free Hospital - Case A • Female 41 years • Liver transplant in Feb 2017 for PBC. • Stable at clinical follow-ups until July 2017 when a liver biopsy was performed for worsening graft function (ALT 210, AST 161, bilitubin 41). • ? rejection.
Royal Free Hospital - Case A
Royal Free Hospital - Case A
Royal Free Hospital - Case A HE DPAS
Royal Free Hospital - Case A
Royal Free Hospital - Case A
Royal Free Hospital - Case B • Female 36 years • Patient underwent transplant on 28.03.17 for PSC, receiving a split graft. • She developed graft dysfunction due to hepatic artery thrombosis and required supraurgent re-transplantation on 06.04.17. • The time zero liver biopsy at the 1st transplantation was negative for C4d. • The slides submitted are from the second transplantation (split graft) and post transplant liver biopsy performed on day 5 after the second transplant. • Split graft/second explant - slides 381810 and 381811. • Day 5 - slides 381812 and 381813.
Split graft/second explant slide 381810
Split graft/second explant slide 381810
Split graft/second explant slide 381810
Split graft/second explant slide 381810
Split graft/second explant slide 381810
Split graft/second explant slide 381810
Split graft/second explant slide 381811 – C4d
Split graft/second explant slide 381811 – C4d
Split graft/second explant slide 381811 – C4d
Further clinical information • Positivity for donor specific antibodies • Treatment with cycles of plasma exchange
Day 5 - slides 381812
Day 5 - slides 381812
Day 5 - slides 381812
Day 5 - slides 381813 – C4d
Day 5 - slides 381813 – C4d
Day 5 - slides 381813 – C4d

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Nutrition Status pre Liver Transplant and Length of Hospital Stay post Liver Transplant N .

Nutrition Status pre Liver Transplant and Length of Hospital Stay post Liver Transplant N . OSullivan , D D. Houlihan, National Liver Transplant Unit St Vincents University Hospital, Dublin 4 Background ESPEN states that

513 views • 19 slides

Liver Transplant and Etiology Which of the following is the most Liver Transplantation for

10/2/2017 Asian Health Symposium 2017 Liver Transplant and Etiology Which of the following is the most Liver Transplantation for common indication of liver transplant now in the United States? Hepatocellular carcinoma (HCC) HCV

304 views • 7 slides

Live Donor Liver Transplant at UPMC Changing the Paradigm Abhi Humar, MD Clinical Director,

Live Donor Liver Transplant at UPMC Changing the Paradigm Abhi Humar, MD Clinical Director, Starzl Transplant Institute 1 No financial disclosures related to this presentation 2 PITTSBURGHTHE BIRTHPLACE OF LIVER TRANSPLANTATION Liver

616 views • 45 slides

2017 UNOS Liver Distribution Proposal Discussion: David Goldberg Who am I? Transplant

2017 UNOS Liver Distribution Proposal Discussion: David Goldberg Who am I? Transplant hepatologist at the University of Pennsylvania Medical Director of Living Donor Liver Transplant NIH-funded epidemiologist and health services

400 views • 14 slides

9/29/2016 UCSF Transplant 2016: Building Bridges to Excellence OVERVIEW Current state of

9/29/2016 UCSF Transplant 2016: Building Bridges to Excellence OVERVIEW Current state of liver transplantation (LT) Liver Transplant for Hepatocellular for HCC Carcinoma (HCC): What is New? Lets push past the Milan criteria

734 views • 18 slides

Disclosures Rehabilitating Pre- and Post-liver I have nothing to disclose transplant Patients

9/30/2016 Disclosures Rehabilitating Pre- and Post-liver I have nothing to disclose transplant Patients Michelle Oberst, PT, DPT, GCS, CEEAA Alicia Rivas MS, OTR/L Objectives Role of Therapy in Acute Care Understand the role of physical

139 views • 9 slides

JAMES Y.Y. FUNG Liver Transplant Center, Queen Mary Hospital Department of Medicine, The

JAMES Y.Y. FUNG Liver Transplant Center, Queen Mary Hospital Department of Medicine, The University of Hong Kong State Key Laboratory for Liver Research Decompensated Cirrhosis Death 5-7%/yr Decompensated Cirrhosis ~2 yrs >12 yrs

771 views • 23 slides

Case Chronic Dyspnea 58 y.o. male, s/p orthotopic liver transplant in 2004 for Hep C,

Case Chronic Dyspnea 58 y.o. male, s/p orthotopic liver transplant in 2004 for Hep C, presents with mild-moderate Clinical Perspectives dyspnea on exertion x 5 years Symptoms more noticeable recently, and have occurred: Roy Essig, M.D.

508 views • 14 slides

Disclosures Donor selection in pediatric liver transplant I have nothing to disclose Garrett R.

9/30/2016 Disclosures Donor selection in pediatric liver transplant I have nothing to disclose Garrett R. Roll, MD Assistant Professor of Surgery Overview Basics Graft types: Growth failure Living donor (LD) Deceased donor (DD)

239 views • 9 slides

Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy F.R.

Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences 2017; 21 (1 Suppl): 23-36 Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy F.R. PONZIANI 1 , S. BHOORI 2 , M. POMPILI 1 , M.A. ZOCCO 1 , M.

147 views • 14 slides

My background I have been with UCSF for 30 years and it has all been with the Transplant Service.

9/30/2016 My background I have been with UCSF for 30 years and it has all been with the Transplant Service. I started as a staff nurse and then went on to be a kidney transplant coordinator for about 18 years and then moved over to the Liver

292 views • 8 slides

Liver Transplant Presentation Form Site: Click or tap here to enter text. Clinician: UCSF PLEASE

Liver Transplant Presentation Form Site: Click or tap here to enter text. Clinician: UCSF PLEASE NOTE that TTS-ILT case consultations DO NOT create or otherwise establish a provider-patient relationship between any UCSF clinician and any patient

290 views • 5 slides

Liver Update Meeting Nottingham Nov 14 2006 Case Presentation Female, born 1978 Presented in

Liver Update Meeting Nottingham Nov 14 2006 Case Presentation Female, born 1978 Presented in 2002 with multiple liver lesions ?nature Oral contraceptive pill use. No other medical history Liver biopsy fibrosis?cause Liver

479 views • 20 slides

Updates in Nonalcoholic Fatty Liver Disease (NAFLD) Danielle Brandman, MD, MAS Program Director,

Updates in Nonalcoholic Fatty Liver Disease (NAFLD) Danielle Brandman, MD, MAS Program Director, Transplant Hepatology Fellowship Director, UCSF Fatty liver clinic Associate Professor of Medicine Disclosures Allergan, Gilead, NGM, Grifols:

1.07k views • 63 slides

Objectives for Today Learn every aspect of liver, pancreas and kidney organ transplantation

10/22/2018 Abdominal Transplantation: Innovations and Emerging Trends Amit D. Tevar, MD Associate Professor of Surgery Starzl Transplant Institute University of Pittsburgh Medical Center Objectives for Today Learn every aspect of liver,

516 views • 38 slides

Transplant Debate: How Old is Too Old for Kidney Transplant Chris E. Freise, M.D UCS F

9/26/2018 Transplant Debate: How Old is Too Old for Kidney Transplant Chris E. Freise, M.D UCS F Professor of S urgery Interim Chief of Transplant More Difficult Decision What if no living donor ? L.D., 86 yo male, ESRD from HTN,

323 views • 8 slides

Team Cymru Cymru Team Penetration Testing Ryan Connolly, ryan@cymru.com

Team Cymru Cymru Team Penetration Testing Ryan Connolly, ryan@cymru.com <http://www.cymru.com> Penetration Testing Agenda Pentesting Basics Pentesting Defined Vulnerability Scanning vs. Penetration testing Pentesting

879 views • 83 slides

Abstract ID: 12 Presenting Author: Saranya Devi K Co-Authors: Anushree Mishra Anita Ganger

Abstract ID: 12 Presenting Author: Saranya Devi K Co-Authors: Anushree Mishra Anita Ganger Rohit Saxena Madhulika Kabra Abstract Title: Evaluation of the effect of secondary mitochondrial DNA mutations in Lebers hereditary optic

317 views • 7 slides

5 minutes: Attendance and Breath of Arrival 50 minutes: Urinary System Punctuality-

5 minutes: Attendance and Breath of Arrival 50 minutes: Urinary System Punctuality- everybody's time is precious: Be ready to learn by the start of class, we'll have you out of here on time o Tardiness: arriving late, late return after

651 views • 42 slides

Geriatric Acetabular Fractures Avoid Complications Adam Starr, MD Chief, Orthopaedic Surgery

Geriatric Acetabular Fractures Avoid Complications Adam Starr, MD Chief, Orthopaedic Surgery Parkland Memorial Hospital Professor and Executive Vice Chair Department of Orthopaedic Surgery UT Southwestern Medical Center Dallas, Texas 69

1.11k views • 37 slides

Checkmate? Review of the Epidemiology and our Last Line of Defense for Carbapenem-Resistant

Checkmate? Review of the Epidemiology and our Last Line of Defense for Carbapenem-Resistant Enterobacteriaceae Kieran Shah, Clinical Pharmacy Specialist Critical Care, Surrey Memorial Hospital Presenter disclosure I have no current or past

744 views • 50 slides

Neonatal X-Ray Interpretation Smeeta Sardesai, MD, MS Ed. Associate Professor of Pediatrics Keck

Neonatal X-Ray Interpretation Smeeta Sardesai, MD, MS Ed. Associate Professor of Pediatrics Keck School of Medicine University of Southern California University of Southern California Los Angeles Why X-Rays are Done? X-rays are ordered:

269 views • 26 slides

UNIVERSIT DI BOLOGNA INTERNATIONAL MASTER DEGREE IN PULMONARY VASCULAR DISEASES 2019 2020

UNIVERSIT DI BOLOGNA INTERNATIONAL MASTER DEGREE IN PULMONARY VASCULAR DISEASES 2019 2020 EDITION The University of Bologna has established in 2006 the International Master Degree on Pulmonary Vascular Diseases (MPVD) to be held at the

338 views • 4 slides

Evaluating methods to capture stakeholder preferences MACBETH: A Non-numerical Method for

Evaluating methods to capture stakeholder preferences MACBETH: A Non-numerical Method for Eliciting Preferences Presented by: Andrea Beyer EMA/ UMCG Collaboration An agency of the European Union Acknowledgements IMI-PROTECT WP5 Prof.

636 views • 27 slides